Environment Secretary Michael Gove said: "We are a nation of animal lovers, and the use of these punitive devices can cause harm and suffering, whether intentionally or unintentionally, to our pets.
"Organisations and MPs have campaigned against the use of shock collars passionately and we are listening to their concerns.
"We are now proposing to ban the use of electric shock collars to improve the welfare of animals."
Defra has launched a consultation on the proposals, which you can take part in here: https://consult.defra.gov.uk/animal-health-and-welfare/ban-on-electronic-training-collars-cats-and-dogs/
BVA President John Fishwick said: "We welcome the Government’s launch of a consultation on banning the use of shock collars in England and would like to see it result in an effective ban soon.
"Electronic training devices such as shock collars have been proven to cause pain and unnecessary suffering, and we know from leading veterinary behaviourists that using fear as a training tool is less effective than positive training methods, such as encouragement or rewards, and can take a toll on an animal’s overall welfare.
"We were in Westminster last week along with several animal welfare charities to highlight the issue and call upon Members of Parliament to back a ban on the use of shock collars. We were pleased to see several MPs pledge their support."
BVA will continue to push for an outright ban on the sale and import of shock collars across the UK.
Photo: Electric shock collar / Petrovskii Ian / Shuterstock
Newmarket-based Test and Treat was one of three finalists, for its U-Treat test which enables vets to diagnose a UTI and get antibiotic sensitivity results in an hour.
Rachel Kirkby MRCVS, Business Development Director at Test and Treat, said: "It’s a great accolade to be recognised by such a prestigious award. The Vet Record Innovation Award celebrates new innovations that can bring about improvement and make a real difference to vets in practice – and that’s exactly what we’re aiming to do with U-Treat.”
The second finalist was the Animal Welfare Assessment Grid, developed by Public Health England (PHE), in collaboration with the University of Surrey School of Veterinary Medicine. Initially developed in zoos, rescue and research centres, there are plans now to develop it for use in small animal practice and in the farm sector.
The overall winner was PBD Biotech for Actiphage, its test for bTB and Johne's disease which gives very early detection, thereby allowing vets and farmers to prevent the spread of infection.
For more information, visit: https://bvajournals.onlinelibrary.wiley.com/doi/10.1002/vetr.267
Ceva says the course is aimed at vets and nurses who want to build their confidence and take the lead in finding hypertension in cats in their clinic.
The course is hosted by Sarah Caney BVSc DSAM(Feline) MRCVS, one of the UK's leading specialists in feline medicine, and will cover things like finding out which cats need screening for feline hypertension, how to become confident in recommending a blood pressure check to owners, hints and tips on taking a reliable blood pressure measurement and handling cats calmly to reduce ‘situational hypertension’.
The course consists of four 30-minute recorded sessions including course notes and self-assessment questions for each module. Once completed, the delegate will receive a Hypertension Ambassador pin badge and a certificate for four hours’ CPD. The first 500 delegates to complete the course will be offered either a cat hide or an eye atlas.
The course can be completed online at any time. There are also weekly feline hypertension live sessions at 1pm, from Wednesday 4th March until Wednesday 25th March. They offer the opportunity for you to ask questions, but they're also recorded so you can watch them any time thereafter.
Suzanne Page BVSc MRCVS, cardio-nephrology-hypertension product manager at Ceva Animal Health, said: "Our HypertensionAmbassadors’ initiative will educate veterinary professionals on every aspect of feline hypertension to enable them to confidently talk to their clients about the condition, measure blood pressure in a cat-friendly way and offer advice on the different treatments available."
For more information, and to register, visit www.veterinarywebinars.com/feline-hypertension-ambassador.
In the Horiba-sponsored webinar, Kit will draw on personal experience and case study examples to illustrate how the innovative use of adjunctive tests can support rapid clinical decision-making when triaging patients.
For example, Kit will consider whether inflammation markers such as C-reactive protein (CRP) and serum amyloid A can be used to assess if current signs are likely associated with inflammatory diseases, such as pancreatitis, or whether further investigation is required to determine cause of illness.
Kit will also consider the case of Ollie a 10-year-old German shorthaired pointer presenting as vaguely unwell with reduced appetite.
Is this just a flare-up of his chronic osteoarthritis and likely to respond to pain relief and anti-inflammatory treatment, or something else?
Attendees will be able to questions in a live Q&A session at the end of the webinar.
Horiba's team will also be on hand to answer questions on in-house diagnostics.
For free registration, visit: https://bit.ly/3wGADcm
VetYogi’s new ‘VetYogi Collective’ offers an on-demand online hub of yoga, mental health and wellbeing sessions designed to meet the individual needs of vets, RVNs, practice managers, receptionists, students and paraprofessionals.
Subscription includes a monthly live yoga session and access to a library of content which includes yoga sessions lasting from minutes to over an hour.
There are also videos, and advice on guided meditation to help support wellbeing and manage stress.
Chloe says: “It’s important that everyone who has a need, has access to the type of wellbeing tools that they respond best to, so we have developed self-care sessions for all roles in the profession.
"If you have had a hard day or a stiff neck from working in theatre for hours, or are just feeling tense and unable to switch off, you need help there and then.
"The VetYogi Collective provides that support around the clock which we simply couldn’t deliver any other way.”
Individual subscriptions cost £12 per month.
Practices signing up their team are offered preferential rates and can use the VetYogi Collective badge on their materials to signal their commitment to supporting wellbeing.
collective.vetyogi.com
Pfizer has repeated it's call for veterinary practice staff to take part in its Vet Support+ independent, industry-wide survey of employee engagement.
The survey gives practice team members, who are not partners or owners, the chance to have their say about their role and career and the future of the profession. Participants are asked to consider how they feel towards their practice and delve into issues on teamwork and communication, management techniques, personal development opportunities and working environment.
More than 3,000 vet practice staff have already completed the survey, a phenomenal early response which suggests practice employees are keen to have their voices heard. However, the closing date for the survey isn't till Friday 29th July, so if you haven't yet had a chance to do the survey, there is still time.
Pfizer Business Consultant, Vanessa Wilson, has more than 20 years experience helping businesses, teams and individuals achieve their goals. She is not surprised at the significant early response: "Questions on the level of employee engagement and satisfaction come up all the time in the work we do with practices. I'm not surprised that staff are using this opportunity to have their voice heard.
"Once completed, this survey will provide some very useful data and direction for the industry as a whole and I'd like to think it will identify opportunities for both individual career development and practice growth."
All members of staff employed within a practice who have not received a mailing and wish to participate are welcome to respond online. http://www.noesis-mi.com/surveys/employeesurvey/.
Pfizer says the findings, which are expected to be released in the autumn, will deliver a national and regional view of the current employee engagement landscape.
For further information about Vet Support+ Business Services from Pfizer visit www.vetsupportplus.co.uk.
Dechra Veterinary Products has launched Buprenodale, an opioid analgesic for cats, dogs and horses presented in a 10ml multi-dose vial.
Carol Morgan, Brand Manager said: "Following on from the introduction of Comfortan and Anesketin, our Buprenodale Multidose, 0.3 mg/ml solution for injection for dogs, cats and horses, is the latest addition to the portfolio.
"The active substance in Buprenodale is buprenorphine, the most commonly used opioid analgesic in small animal practice in the UK.
"Buprenodale Multidose joins a portfolio of Dechra products covering a wide range of species, different levels of analgesic efficacy and duration of action.
"The product is now available in a 10 ml multidose vial. It is suitable for post-operative analgesia in dogs and cats; post operative analgesia, in combination with sedation, in horses and potentiation of the sedative effects of centrally acting agents in the dog and horse."
For more information www.dechra.co.uk .
The Disciplinary Committee took the unusual step of granting an application by the respondent for anonymity, after seeing evidence of a real and immediate threat to the individual’s security if their details were made public.
For the purposes of the hearing, the respondent was therefore referred to as 'X'.
The Committee heard that the individual pleaded guilty in court in 2020 to intentionally and knowingly attempting to communicate with a person under 16 years for the purposes of sexual gratification.
Following this they were sentenced to a two-year probation order, were ordered to register on the Sexual Offences Register for five years; and were made subject to a Sexual Offences Prevention Order for five years.
At the outset of the hearing the individual admitted to all the charges against them and the Committee also noted that there was a certified copy of the conviction available.
The Committee then considered whether the conviction amounted to serious professional misconduct. In considering this, it set out the aggravating factors surrounding the case, these being that there was the risk of actual harm to a minor, that the misconduct was premeditated as the respondent had sent a number of messages via a number of online platforms over several days, that the individual displayed predatory behaviour including sending pictures and making comments of a sexual nature, and that it involved what the respondent believed to be a vulnerable individual, namely a 15-year-old child.
In mitigation, the Committee considered that there had been no actual harm caused to a human or animal in light of the fact that the 15-year-old child, who the respondent believed they were communicating with, was not real. It also took into account that the conduct related to a single isolated incident and that the individual had made open and frank admissions at an early stage.
Cerys Jones, chairing the Committee and speaking on its behalf, said: “The Committee was satisfied that the sentence imposed on X, which included X being subject to a Sexual Harm Prevention Order until 2025, resulted in the profession of veterinary nurses being brought into disrepute and, in the Committee’s judgement, public confidence in the profession would be undermined if the Committee did not find that the conviction rendered X unfit to practise as a veterinary nurse.”
In considering the individual’s sanction, the Committee heard from a character witness who said that the respondent’s actions were out of character, that they had a previously long and unblemished career, that they had made full admissions and demonstrated insight, and that they had a low risk of reoffending in the future.
Cerys said: “The Committee accepted that X had been an excellent veterinary nurse and that X’s criminal conduct did not relate to X’s practice as a veterinary nurse. However, in the Committee’s judgement, the aggravating factors outweighed the considerable mitigating factors in this case.”
She added: “The Committee decided that a suspension order was not the appropriate sanction for such a serious offence because it did not reflect the gravity of X’s conduct. In the Committee’s judgement, the wider public interest, that is the maintenance of the reputation of the profession and the College as a regulator, required a sanction of removal from the Register. The Committee considered that X had much mitigation and was clearly a dedicated veterinary nurse but the reputation of the profession was more important than the interests of X.
“Further, the Committee noted that in circumstances where X’s probation order expired in 2022, and where the ancillary orders, a Sexual Harm Prevention Order and a requirement to register on the Sexual Offences Register did not expire until 2025; the only proportionate sanction was to direct the Registrar to remove X’s name from the Register of Veterinary Nurses.”
The full findings for the case can be found at: www.rcvs.org.uk/disciplinary
Fort Dodge has unveiled an initiative to help practices improve peri-operative care and the management of hospitalised cases with the launch of its Early Warning Scoring System (EWSS) kit.
The kit contains cat and dog anaesthesia and observation charts for the effective monitoring of cats and dogs during operations, post-operatively and for hospitalised medical cases.
EWSS observation charts are widely used in the NHS but this is believed to be the first time that such a system has been developed specifically for use in veterinary practices.
They have been designed by Mike Davies BVetMed CertVR CertSAO FRCVS, Technical Services Manager at Fort Dodge, and are intended to help veterinary nurses and veterinary surgeons identify patients whose condition is deteriorating before they reach a critical state.
Mike Davies speaks around the country on preventive medicine and geriatrics and his experience of working closely with practices is that many do not have good protocols in place for nurse monitoring of patients. The EWSS grades parameters such as heart rate, respiratory rate, blood pressure and CNS response and the charts incorporate areas in which the practice can record pain using a visual analogue scale or a numeric scoring system.
The company has also launched Dorbene vet, a new product providing fast-acting sedation and analgesia for dogs and cats. Its active ingredient is the trusted and well proven alpha-2 agonist medetomidine hydrochloride, which affects the nervous system by inhibiting noradrenaline mediated neurotransmission. A dosing guide for Dorbene vet is also included in the EWSS.
The launch of Dorbene vet complements Fort Dodge's existing companion animal products, analgesic Torbugesic and dissociative anaesthetic Ketaset. Used alone it offers dose-related sedation within 10-15 minutes, which is rapidly reversible using the alpha-2 antagonist atipamezole for predictable recovery. It is presented in 10 ml and 50 ml multi dose vials in amber coloured glass which protects the product from light.
For further information on the EWSS or Dorbene vet, contact Fort Dodge on 01489 781711.
CEVA Animal Health is giving away a digital thermometer with every purchase of three bottles of Rehydion gel Formula Plus
According to CEVA, dehydration can be a big problem for farmers, causing weakness, scouring and weight loss but Rehydion gel Formula Plus has transformed the management of this common condition. Historically treatments could not be added to milk as the bicarbonate, citrate and the high levels of glucose in the solutions inhibited milk clotting. Rehydion gel Formula Plus, however, helps to maintain a low abomasal pH and guarantees milk clotting.
The company says calves with dehydration and diarrhoea still tend to crave milk, which not only provides vital fluid but is also the best possible source of energy for weight gain. Milk also has many other advantages such as helping with gut healing and providing natural antimicrobial actions. Rehydion gel Formula Plus's high palatability and efficient dilution in milk allows weight gain to continue, even in cases of severe scour.
CEVA also has a leaflet to help farmers minimise the problem of dehydration and diarrhoea in beef and dairy cattle. To order copies and for further information contact your CEVA representative or CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
The change to the Practice Standards rules means that RVNs who have at least five years’ experience within the profession are eligible to apply to become PSS Assessors.
PSS Assessors are employees of the RCVS who are responsible for visiting practices that want to join the scheme, are undergoing their re-accreditation assessment or have applied for one or more of the PSS Awards, to ensure they meet the criteria.
The decision to allow RVNs to become PSS Assessors had already been approved by both the Practice Standards Group (the steering committee for the Scheme comprising representatives from all of the major veterinary and veterinary nursing organisations in the UK) and the RCVS Standards Committee.
Matthew Rendle is the Chair of VN Council and also sits as a member of RCVS Council. He said: “I am delighted to see that there is now a pathway to recruit veterinary nurses as PSS Assessors and hope that many of my VN colleagues will take up this opportunity to apply to join the excellent team responsible for ensuring that the Scheme’s stringent standards are met.
"We know that, on a practice-by-practice basis, veterinary nurses often play a big role in helping to coordinate and ensure that the requirements of the Practice Standards Scheme are met, for example, by preparing their team for the assessment, liaising with the RCVS and the Assessor and making sure all standards are complied with in advance. It is great to see that the crucial role they often play in meeting standards is reflected in opening up the ability to become PSS Assessors."
Mandisa Greene, RCVS President and Chair of the Practice Standards Group, added: “This is such an important development for the veterinary nursing profession whose role in the Practice Standards Scheme has long been recognised as invaluable. This decision also opens up new career advancement opportunities for the profession as well, which I’m sure is very welcome."
When the next recruitment round for PSS Assessors takes place, RVNs will be invited to apply to join the roster of Assessors.
In addition to approving the role of RVNs as PSS Assessors, Council also approved a new Equine Emergency Services Clinic accreditation to help incorporate the emerging business model of veterinary practices that provide ambulatory emergency services for equids.
The new accreditation would require these practices to meet the applicable PSS Core Standards, plus the requirements contained in an additional Equine Emergency Services module. The full details of the requirements will be published in due course.
For more information about the Practice Standards Scheme visit: www.rcvs.org.uk/pss
The gallery was traditionally held in-person at the NAVC’s annual Veterinary Expo & Meeting (VMX) in Florida.
Now, for the first time since it began in 2012, the gallery is accessible to everyone everywhere months before the live event in June.
The new Virtual VMX New Product Gallery went live this week and will run until 3rd September 2021. It showcases 21 new product innovations from the following companies: BioNote; Boehringer Ingelheim Animal Health; Dechra Veterinary Products; Epicur Pharma; GVL; Hill’s Pet Nutrition, Inc.; Merck Animal Health; Neogen Corporation; Ogena Solutions; Purina; Royal Canin; Vetoquinol; Zoetis Petcare.
NAVC CEO Gene O’Neill said: "Each year, NAVC’s panel of experts select the most innovative new products and services to be showcased as part of the VMX Expo. We are excited to take this VMX staple and, for the first time, make it universally available to members of our global veterinary community everywhere.
"And they don’t have to wait until June to learn about and try these important new products. The VMX Virtual New Product Gallery launch is part of the NAVC’s expanding virtual portfolio which breaks down barriers of geography and time to make the best products the veterinary industry has to offer available to veterinary professionals worldwide.” The gallery is free to access. You can register here: https://vmxvirtual.simexpo.com/page/100
TwistPak bottles have a hygienic interlock at the bottom, which allows them to be connected with a twist, creating one single mixing chamber which fits in all standard vaccination devices.
Currently, freshly mixing two vaccines requires a transfer needle.
Boehringer says the TwistPak bottle simplifies the mixing process while retaining the flexibility of using the products as a monovalent or combined vaccine.
TwistPak was jointly created with the industrial design and product development company DESIGNquadrat and awarded a Red Dot Design Award 2021 in the product design category.
Eva Joras, Global Brand Manager at Boehringer Ingelheim said: “TwistPak revolutionizes how vaccines are mixed.
"The mixing platform combines the best of both worlds: the unparalleled quality and efficacy of freshly mixed vaccines with the convenience of ready-to-use solutions.
TwistPak will be globally available in all registered presentation sizes starting May this year.
The results of the UK's first ever public National Equine Health Survey have quantified non-notifiable healthcare issues affecting horses, ponies, donkeys and mules in the UK.
The survey, which was pioneered by The Blue Cross animal charity and is supported by The British Equine Veterinary Association, was carried out last November following two years of pilot schemes. The intention was to find out more about endemic non-notifiable diseases that have never before been recorded in horses, ponies, donkeys and mules, such as coughs, skin diseases and lameness.
The results were announced at the National Equine Forum by Professor Josh Slater, Professor of Equine Clinical Studies at The Royal Veterinary College, who has been working with The Blue Cross on the survey.
A total of 306 sets of records were submitted from 3120 horses in mainly private ownership, with a balance of representation from competition yards, riding schools, welfare charities and studs. A broad range of syndromes and diseases were assessed including colic, sarcoids, laminitis, wounds, dental issues, eye disease, lameness and weight issues.
The results showed that lameness was the most common problem affecting horses (11% of horses surveyed) but that the foot was not the most common cause of lameness and that laminitis (3%) was less common than the 7-8% total that previous surveys had suggested.
Weight management was the next most common issue for horse owners, with 9% of horses recorded as overweight and 8% as underweight. These figures are lower than previous surveys which may be because they are based on the owner's assessment of their horse's weight which is subjective and may vary according to their perception of 'the right weight'.
Skin disease and wounds (5% and 4% respectively) posed a significant problem and colic (2%) was also a common occurrence, with a 6:1 ratio between medical and surgical cases.
The survey is breaking new ground in Europe as well as the UK. Currently Government agencies in all European countries conduct surveillance for prescribed exotic diseases such as West Nile Virus and African Horse Sickness but currently there are no large scale surveillance programmes for endemic diseases.
Professor Slater said: "The regular collection of such data holds numerous benefits to the UK equine industry. Not only does the survey provide a benchmarking facility for equine disease, welfare, standards of care and codes of practice but it will also underpin standards for yard inspection schemes. Not least it confirms the workability of an important template to monitor the serious threat of infectious and exotic disease in the future."
He added: "It's exciting to see hints in the NEHS 2010 survey that data 'straight from the horse's mouth' might challenge some established ideas. For example; the survey found that lameness was common, as you would expect, but that the foot was not the most common cause of lameness, which you might not have expected. This kind of data has never been collected before and is invaluable to the veterinary profession and wider animal welfare industry, helping to inform our future research, training and education. It will be really exciting to see the results of the larger surveys The Blue Cross are running in 2011."
Kerry Doyle, education officer at The Blue Cross said: "We are thrilled to be involved with this innovative project to enhance the future health of our horses and very grateful to all those who have participated in the survey so far. We now need even more horse owners to sign up for the next round so that we can capture as much useful data as possible."
The National Equine Health Survey is currently funded by The Blue Cross but sponsorship is being sought. It is to be conducted twice-yearly with the next census week planned for 9-15 May 2011. All keepers and owners of horses are urged to participate and details of all horse owners will remain anonymous. It's very quick and easy to complete and should only take around five minutes. To register online visit www.bluecross.org.uk/NEHS or email NEHS@bluecross.org.uk.
Homeopathy is widely used in livestock, especially to replace or reduce the use of antibiotics in the treatment of infectious diseases, although its use is often seen as controversial. For organic agriculture, homeopathy is even promoted.
In the review, Dr Caroline Doehring and Professor Albert Sundrum from the University of Kassel, Germany, assessed peer-reviewed studies on the efficacy of homeopathy in cattle, pigs and poultry published between 1981 and 2014.
They analysed a total of 52 clinical trials, 34 with cattle, 12 with pigs and six with poultry. They were published in 48 publications.
Of these, 28 concluded that the homeopathic remedy administered was effective, 22 showed no efficacy and 2 were inconclusive.
Only 10 trials provided information on cure rates for the treatments. These varied to a high degree, while the remedy used did not seem to make a big difference.
Trials on pigs were frequently efficacious, while studies with cattle or poultry had a similar distribution of efficacious and non-efficacious treatment.
Double-blind randomised controlled trials reported efficacy of the homeopathic treatment almost as often as they reported lack of it.
Meanwhile, single-blind and non-blind randomised controlled trials, and observational trials were more likely to present evidence of efficacy, suggesting that positive outcomes may be due to bias.
Other study limitations, such as potential conflict of interests, low sample size, risk for selective reporting and bias, were found in the majority of trials.
While some clinical trials showed effectiveness, the authors of the review question the reliability of the evidence, because all studies had a range of limitations. For example, all clinical trials were conducted under very specific conditions and none were repeated under comparable conditions.
Therefore, the authors say the findings cannot be be used to recommend homeopathy: "The current evidence of studies providing evidence in favour of homeopathy lacks reproducibility and therefore cannot claim to have sufficient prognostic validity."
"Due to a lack of prognostic validity, replacing or reducing antibiotics with homeopathy currently cannot be recommended unless evidence of efficacy is reproduced by RCTs and proven in various farm practice conditions."
In mid-September, the Association wrote to the RCVS expressing concern about the August extension to the temporary guidance.
In the latest update from the RCVS, the temporary measure has now been extended to 31 October but the flowchart and guidance have been updated to add some additional steps before a POM-V product can be prescribed remotely.
The BVA says that while it supported the original decision in March as a pragmatic solution and direct response to government restrictions surrounding Covid-19, it is now questioning the ongoing need for such a relaxation in the rules.
In the letter to the RCVS, the BVA also asked for a timeframe for the publication of the results of the RCVS survey of practices’ experiences of remote consulting and prescribing. The Association's own under care working group, chaired by Nigel Gibbens, has been developing a position to respond to the RCVS review.
BVA President James Russell (pictured right) said: "We understand that allowing remote prescription of POM-Vs was a necessary measure at the height of the lockdown, as practices struggled to assess patients in person.
"However, the veterinary professions have done a fantastic job in adapting to the restrictions and are now able to work safely and see patients.
"Whilst we recognise the RCVS has provided additional guidance for the remote prescribing of POM-V, we cannot currently see any reason why a new client would be unable to access in-person veterinary care in the first instance and we are asking RCVS Council to reconsider this measure when it meets in Oct.
"It makes sense to continue allowing vets to remotely prescribe for existing patients, for example if an owner is shielding, but we feel it is no longer appropriate to be remotely prescribing to animals that have never been physically examined by the vet.
“The question of whether we should be able to remotely prescribe POM-V products without first seeing an animal is an important and live debate, and we welcome the resumption of the College’s review. But the longer that temporary measures are in place, the greater the expectation from animal owners that they will always be in place, and the harder it will be to have the discussion about the best way forward.
“As a profession, we are rightly concerned about antimicrobial resistance and we pride ourselves on the responsible use of medicines. Continually extending the temporary measures without a full analysis would risk undermining our position.”
He takes over the role from Huw Griffiths at the end of BEVA Congress 7th -10th September 2022. Roger Smith becomes President Elect.
Following graduation from The University of Bristol in 2001, David worked in farm animal and equine practice in Somerset before completing an internship at Liphook Equine Hospital.
A three-year Horserace Betting Levy Board residency at The University of Glasgow and Liphook Equine Hospital enabled him to train as a specialist in equine internal medicine and to gain a masters by research into equine asthma and an RCVS certificate in equine medicine.
David spent several years at Liphook Equine Hospital in Hampshire and had spells at The Royal Veterinary College, London and Charles Sturt University in Australia before moving to Rainbow Equine Hospital in Yorkshire where he led the internal medicine and laboratory services as a director and subsequently a clinical director following the hospital’s acquisition by the VetPartners group.
David returned to his Westcountry roots in 2020 and now combines work as an independent equine medicine and therapeutics consultant with running the family farm on the edge of Exmoor.
He is chair of BEVA’s health and medicines committee.
During his presidential year David is keen to continue build on his recent work around antimicrobial and anthelmintic resistance as well as expanding BEVA’s global outreach to support more equine vets and have a greater impact on equine welfare.
He said: “I’ve had a great time being part of the profession for the past 20 years and I am now in a position to give something back.
“Huw has driven much activity in the past year around recruitment and retention and I hope to be able to build on this and action results from the recent survey, under Huw’s continued supervision. I am also determined to maintain momentum around BEVA’s antimicrobial and anthelmintic resistance work as well as step up collaboration internationally on these and other projects to extend BEVA’s global outreach.
“Around 99% of the world’s horses are cared for by around 1% of the world’s vets so we are not going to change things overnight; however, BEVA has so much to offer and we should use our resources to support equine welfare, irrespective of where equine vets and their patients live and work.”
Presented by Sam Taylor BVetMed(Hons) CertSAM DipECVIM-CA MANZCVS FRCVS, the webinar will also be available to watch on demand later, for those who miss it.
Sam is an Internal Medicine and Feline Specialist and current ISFM Academy lead.
She recently chaired and co-authored the ISFM guidelines on the management of the inappetent hospitalised cat.
The webinar, which counts for one hour’s CPD, will cover:
Sarah Musgrave, Brand Manager at Dechra, said: “Inappetence is a common reason cats present to veterinary practices and it can be caused by multiple conditions.
"Management needs to look beyond just treating the underlying disease as factors such as stress, nausea and pain can play a significant role.
"Untreated inappetence has a substantial negative effect on recovery from illness and surgery, makes medicating cats difficult and may even hasten euthanasia decisions.
"The ‘Feline pawsative about feline inappetence?’ webinar will help educate on feline weight loss, why intervention to improve nutrition is important and the practical steps to treating inappetence.”
https://thewebinarvet.com/webinars/feline-pawsative-about-feline-inappetence.
Cornerstone Veterinary Clinic, which was founded by Peter Herold in 2011, currently employs a 15-strong team, who are all now practice owners and shareholders in the business.
Peter got the inspiration from reading about how Pennard Vets had become the world’s largest employee-owned practice in order to protect both its independence and core values.
He then contacted the directors at Pennard Vets, who helped guide him through the process.
Peter said: “After starting Cornerstone 11 years ago, we have developed a longstanding, loyal and dedicated team who are all very popular with our established client base across Belfast and beyond.
"I genuinely love Cornerstone, and so do our team and clients, and although I’m not ready to retire yet, the end of my professional life will come in the next decade, so I wanted to start planning for it.
“The obvious option would be to sell the practice to a corporate chain, but I knew that would change how we worked.
"There would be much more emphasis on profit levels, and we’d be forced to make decisions that we were uncomfortable with.
"We have an amazing team who are full of ideas about how to make Cornerstone even better and to guarantee a successful future, the practice needs to continue growing in a way that works for its people, our clients and their pets.
“When I read about Pennard Vets becoming an EOT, it immediately resonated with me, and I hoped it could be an option for Cornerstone.
"I then attended a webinar with speakers from Pennard Vets, and I kept in touch with them afterwards.
"They explained the set-up and how it benefits their team, as well as putting us in touch with specialists in EOTs.
"Ultimately it was Pennard Vets’ knowledge and enthusiasm that convinced me it was the right route for us.”
Peter added: “Our senior team at Cornerstone are all very skilled and share common values in relation to customer service, veterinary care and client charges, and it’s this ethos that makes us popular with clients.
“Making the business an EOT will ensure this continues by safeguarding the future of the business, whilst giving each member of the team the benefit of being a business owner without them having to buy in.
"It also means I can continue to work as a vet, but share the management side of the practice with the entire team who can help to make the important decisions, which is an exciting prospect for everyone involved.”
Matthew Flann from Pennard Vets said: “We became an EOT to maintain our independence and give everyone in our team both autonomy and a voice, as well as preserving our core values around compassion, client focus and continually improving everything we do.
"This came at a time when it’s increasingly difficult for vets to buy into practices and the traditional partner progression model no longer works, which makes EOTs even more appealing and a positive step for the profession as a whole.
“It’s been genuinely transformational for Pennard Vets, and we now regularly hear from practice owners who are exploring becoming an EOT.
"There are now several other successful businesses currently on the journey and when Peter contacted us, we were happy to offer our help and guidance.
"Cornerstone is a successful practice, with a highly skilled and dedicated team, so its independence is worth protecting, and becoming an EOT will give it a bright future.”
Five graduates from St George's University School of Veterinary Medicine (SGUSVM), in the Caribbean island of Grenada, have passed the Statutory Membership Examination of the UK's Royal College of Veterinary Surgeons.
According to the University, SGUSVM graduates have traditionally demonstrated impressive pass rates on this rigorous exam, but this year's 100% pass rate by SGU students - compared with an overall 44% pass rate for candidates overall - is an exceptional result for SGU students, and only the second time it has been achieved in the school's history.
In order to practice veterinary surgery in the UK, all graduates with foreign or Commonwealth qualifications must pass the RCVS examination. The exam consists of two days of written papers, followed by clinical, oral and practical exams at a UK veterinary medical school. Thirty-five St George's graduates have passed into the RCVS since the School's inception in 1999.
The RCVS sets no quota for this Statutory Membership Examination, meaning those who meet the standards will pass, regardless of the number of candidates sitting the exam.
Austin Kirwan, St George's Associate Dean of UK and Ireland Clinical Affairs stated: "St George's School of Veterinary Medicine once again produces an excellent set of results with a 100 percent pass rate for the Royal College of Veterinary Surgeons Statutory Membership Examination for those SGU students who sat the examination. This is a credit to the school in the quality of education it provides, but also an indication of the calibre of person SGU attracts in its student cohort - outstanding success abounds by thinking beyond."
Presenting the graduates with a membership certificate at the Ceremony of Admissions at Belgravia House in London, RCVS President Dr Jerry Davies said: "I was delighted to welcome so many of this year's successful candidates to the College. Whether newly graduated or long qualified elsewhere, all of those registering today have succeeded in meeting the educational and professional requirements that enable them to call themselves veterinary surgeons and to practise in the UK."
Zoetis has relaunched a broad spectrum intramammary treatment for clinical mastitis, as Lincocin Forte S.
For vets seeking to prescribe an alternative first-choice tube, independent mastitis authority Dr Andrew Bradley suggests it could be a logical, efficacious option, offering the combination of two active ingredients (lincomycin and neomycin) not available in other intramammary tubes.1
Zoetis points to studies which show that In combination, these have been found to have much higher efficacy than the sum of the two parts against Staphylococci aureus.2&3
The company says Lincocin Forte is effective against Gram positive and Gram negative pathogens, in particular staphylococcus, streptococcus and coliform bacteria.
In trials, the treatment produced clinical cure rates 21% higher than an ampicillin-cloxacillin comparison in undifferentiated mastitis cases. As first choice treatment for S uberis clinical mastitis, bacteriological cure rates were similar to a penicillin-streptomycin comparison.4 Against S aureus, aesculin-positive streptococci, and E coli, combined clinical-bacteriological cure rates were 175%, 32% and 21% higher respectively with Lincocin Forte S than ampicillin-cloxacillin treatment.
Zoetis vet Jude Roberts said these findings underpin the treatment's relaunch and its suitability as a first choice therapy for new clinical mastitis cases.
Lincocin Forte S is a water-based formulation, which Jude says helps achieve good distribution in the udder and can be easier to infuse that oil-based tubes, particularly into hardened quarters associated with E coli infections.
Dr Bradley adds that water-based formulation is likely to be less irritant to udder tissues than oil-based tubes, and may improve distribution. He also suggests that "not being a fluoroquinolone or 3rd/4th generation cephalosporin may also help vets fulfil their 'appropriate and justified' prescribing responsibilities."
The recommended treatment is one 10ml syringe per infected quarter at each of three consecutive milkings. Milk from treated cows can be sold for human consumption 84-hours after the last treatment.References:
The RSPCA has published the results of a survey which found that teachers in the UK are strongly in support of teaching animal welfare in the classroom, with 93% of respondents stating they would teach animal welfare in the classroom if they had the time.
95% also said that they believe that teaching children about animal welfare would help make them more compassionate and socially aware.
According to the survey of almost 800 teachers across England and Wales, 83% felt animal welfare should be part of the national curriculum. However, some had concerns about how it would be integrated into existing frameworks, and whether it would mean more demands on already overworked teachers.
RSPCA formal education manager Claire Morris said: "We felt it is easy to sit on the sidelines and state that animal welfare should be part of the curriculum, but it is far more practical and helpful to show that it can be done."
To address these concerns, the RSPCA says it created over 90 free lesson plans for teachers, which are linked to the English and Welsh Curricula. Many of the RSPCA's lesson plans overlap in subject areas including Science, Citizenship, Literacy and Numeracy, as well as provide springboards for assemblies and student councils.
Claire added: "We urge the government to consider integrating animal welfare into our children's education as a matter of urgency - as skills such as empathy, compassion and social consciousness have value as a child goes through the education system as well as when they enter adulthood and the world of work."
The RSPCA says this is particularly important because only 70% of respondents knew what the five animal welfare needs - which are central to the Animal Welfare Act - are.
As well as looking at the ethical side of animal welfare, 92% of teachers also expressed a strong preference for lessons specifically on animals' role in food and clothing production. It was felt that with young people better connected than ever before, they have an increasing awareness of social issues and expect higher ethical standards from companies.
The RCVS Disciplinary Committee has dismissed a charge against Nicholas Robert William Horniman MRCVS, a veterinary surgeon from Cinderford, Gloucestershire, that alleged he was guilty of pet insurance fraud, along with one of his clients, and of dishonestly altering clinical records.
The charge was that, between December 1 2008 and June 30 2014, in relation to Cassy, a Labrador retriever belonging to Jayne Bowkett, Mr Horniman:
The Committee heard that Cassy, who had previously been diagnosed with hip dysplasia, had been registered with Pets Barn Veterinary Group in Gloucestershire in May 2008 when Mr Horniman was the Principal and owner of the three-practice group. Cassy was treated at the Cinderford branch of the practice where she received regular prescriptions for her condition.
At some point in 2008/2009, Mrs Bowkett had relayed concerns to Mr Horniman that her current pet insurance policy needed to be renewed, that the renewed policy would not cover Cassy's existing hip problems and that she would be unable to pay for any future operations herself. It was alleged that, in response to Mrs Bowkett's concerns, Mr Horniman told her that they could take Cassy off the practice computer and put her back on under a different insurance policy in a different name.
Mrs Bowkett took out a policy with Petplan, beginning on 13 August 2009, using her father's details instead of her own. It was alleged that Mr Horniman then arranged for new practice records to be set up in the name 'Cassy Griffiths'. These new records were first used substantively in May 2010 when Cassy returned to the practice with hip problems, following which two separate records were maintained for the dog under 'Cassy Bowkett' and 'Cassy Griffiths'.
In August 2010 Dariusz Drozdz MRCVS, a vet who had treated Cassy several times, had been told by Mrs Bowkett that the dog had two separate records. He told the Disciplinary Committee that he queried this with Mr Horniman who suggested that it was a mistake and that they 'RIP' the name Cassy Bowkett. Mr Drozdz disagreed on this course of action but was told by Mr Horniman to 'leave it to me' and the records were then changed to say that Cassy Bowkett had died.
Mrs Bowkett alleged that, at some point in 2011, Mr Horniman explained to her that it would no longer be possible to claim for treatment for Cassy's hip dysplasia under the Petplan policy in her father's name. However, the policy remained active, and was transferred into Mrs Bowkett's name upon her father's death.
In July 2011 Cassy Griffiths was seen by Jennifer Jones MRCVS, a part-time locum vet at the Cinderford practice, who told the Committee that she was puzzled about why there were very few clinical records relating to the animal. A receptionist explained to her that there were two sets of records for the same dog and that Mr Horniman had instructed her to mark the original pet as having been euthanased and close its records and create a second new record for the dog. Ms Jones tendered her resignation shortly afterwards citing concerns that a pet had been 'reincarnated to ensure continued income from insurance claims'. In November 2011 Ms Jones submitted a formal complaint to the RCVS.
During the course of the hearing the Committee heard evidence from Mrs Bowkett, Mr Drozdz and Ms Jones, amongst others.
In giving evidence Mrs Bowkett admitted that she had knowingly engaged in fraud but maintained that at all times she had acted with the knowledge and on the advice of Mr Horniman. However, the Committee found that she was unable to remember any relevant material dates and was unclear about the chronology of events. It was suggested on several occasions that she was lying to the Committee, which she denied. However, the Committee believed that she took no responsibility for her own fraudulent actions but merely blamed Mr Horniman and that she had a strong motive to engage in the insurance fraud.
In regards to the evidence given by Mr Drozdz the Committee noted that he did not record his suspicions of possible fraud, that he continued to treat Cassy Griffiths after he raised his concerns, and that he appeared to have accepted Mr Horniman's assurance that he had dealt with the issue.
The Committee found that Ms Jones was correct in her suspicions that there was only one dog. However, it felt she offered no evidence to support her suspicion that this was part of Mr Horniman's 'scheme to maximise income for the practice' as she alleged in her witness statement.
The Committee also heard oral evidence from and on behalf of Mr Horniman who categorically denied suggesting to Mrs Bowkett that she commit insurance fraud and attempting to cover this up through the maintenance of two separate records. He maintained that it was not until Ms Jones voiced her concerns that he realised that Cassy Bowkett and Cassy Griffiths were the same dog.
The Committee voiced a number of concerns about Mr Horniman's actions and behaviour and, at times, found his evidence to be unsatisfactory. For example, the Committee found it difficult to understand why 'alarm bells' did not ring that he was dealing with only one dog when he prescribed medication for two almost identical dogs in May 2010 when only one was presented for examination. It also queried why, when he became aware that the insurance policy for Cassy Griffiths was fraudulent, practice records were not updated and no attempt was made to contact Petplan to inform them of this, as is clearly advised by the RCVS Code of Professional Conduct.
Furthermore, the Committee was concerned that, in his correspondence with the RCVS, he was less than transparent, candid and honest. The Committee considered this to be unacceptable behaviour from a professional in dealings with investigations undertaken by the regulatory body.
In making its judgment, the Committee had to make a decision on whose account it felt to be more reliable in regards to the first element of the charge.
Noreen Burrows, chairing the Committee and speaking on its behalf, said: "In coming to its conclusion ... the Committee is faced with conflicting evidence from Mrs Bowkett, who is an admitted fraudster, admits to acting dishonestly and to lying to Petplan. This is in contrast to the evidence from the Respondent, who is of good character, had an unblemished personal record over 23 years and is supported by impressive character references."
The Committee found the evidence of Mrs Bowkett to be "vague, lacking in clarity and inconsistent with the facts" and therefore rejected her evidence concerning the first element of the charge. In regards to the second element of the charge, the Committee was not satisfied that Mr Horniman had arranged for or allowed the records to be changed as was alleged. In regards to the third element it found that, since it had already rejected the charge that Mr Horniman suggested to Mrs Bowkett that she embark upon insurance fraud, it was unlikely that Mr Horniman would have acted dishonestly in the manner alleged.
Noreen Burrows added: "In the light of the above findings, all charges against the Respondent are dismissed."
The aim of the week is to help pet owners identify common symptoms of eye disease and to seek prompt veterinary attention where appropriate.
To support the initiative, TVM UK is supplying veterinary practices with a kit to create their own waiting room display to inform owners about the common symptoms of eye disease. Pet owners can obtain further, more in-depth information by scanning a QR code on their smartphone camera which takes them directly to the webpage www.tvm-uk.com/eyehealth.
There is also a ‘Who’s Got Their Eye on You’ mini quiz to help engage clients to see if they can spot one of their pets in the animal line up.
Will Peel, Product Manager at TVM UK said: "Eye problems in pets can sometimes be hard for pet owners to pick up so we have launched Pet Eye Health Awareness Week to raise awareness of common symptoms of poor eye heath so problems can be identified early and pet owners can seek veterinary advice quickly."
For more information, contact your local territory manager, email help@tvm-uk.com or call 0800 0385868. You can find additional eye-health related social media content at: www.tvm-uk.com.
The dog presented to the Neurology and Neurosurgery Service at Pride after the dog's GP vet had diagnosed a tumour.
The neurological examination was consistent with a thoracolumbar lesion and the X-rays showed a radiopaque mass with bony lysis on the third lumbar vertebral body.
Annette Wessmann, an EBVS European Specialist in Veterinary Neurology at Pride said: “We chose to do a CT scan based on examination and the X-rays.
“It confirmed the suspicion of a neoplastic lesion and ruled out other tumoral focus along the rest of the spine and other organs."
A customised titanium implant was designed for the dog's spine in collaboration with BETA Implants.
Rosario Vallefuoco, an RCVS and EBVS Small Animal Surgery Specialist and Head of Small Animal Surgery at Pride said: “It was a case of combining our experience with that of the engineers.
“The original implants had been designed for humans, and we had to imagine what would be required for a dog and work out at every step what changes we would have to make.”
The surgery took place in three different stages, the first being L3 vertebra skeletonization and dorsal lamina removal.
The second step was vertebral body removal.
Finally, the third step was vertebral reconstruction using the designed implants.
The whole procedure took six hours, and the dog was up and walking again within 12 hours.
Subsequent histopathology assessment of the mass confirmed osteosarcoma, so the surgery is being followed up with chemotherapy.
Following the success of the surgery, Pride Veterinary Referrals says it now hopes to help other dogs with similar conditions.
www.prideveterinaryreferrals.com